Previous Article | Next Article 
Molecular and Cellular Biology, January 2002, p. 644-656, Vol. 22, No. 2
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.22.2.644-656.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Germ Line Transmission of the Cdk4R24C Mutation Facilitates Tumorigenesis and Escape from Cellular Senescence
Sushil G. Rane,* Stephen C. Cosenza, Richard V. Mettus, and E. Premkumar Reddy*
Fels Institute for Cancer Research and Molecular Biology, Temple University School of Medicine, Philadelphia, Pennsylvania 19140
Received 2 July 2001/
Returned for modification 6 August 2001/
Accepted 19 October 2001
Mutations in CDK4 and its key kinase inhibitor p16INK4a have been implicated in the genesis and progression of familial human melanoma. The importance of the CDK4 locus in human cancer first became evident following the identification of a germ line CDK4-Arg24Cys (R24C) mutation, which abolishes the ability of CDK4 to bind to p16INK4a. To determine the role of the Cdk4R24C germ line mutation in the genesis of other cancer types, we introduced the R24C mutation in the Cdk4 locus of mice by using Cre-loxP-mediated "knock-in" technology. Cdk4R24C/R24C mouse embryo fibroblasts (MEFs) displayed increased Cdk4 kinase activity resulting in hyperphosphorylation of all three members of the Rb family, pRb, p107, and p130. MEFs derived from Cdk4R24C/R24C mice displayed decreased doubling times, escape from replicative senescence, and escape sensitivity to contact-induced growth arrest. These MEFs also exhibited a high degree of susceptibility to oncogene-induced transformation, suggesting that the Cdk4R24C mutation can serve as a primary event in the progression towards a fully transformed phenotype. In agreement with the in vitro data, homozygous Cdk4R24C/R24C mice developed tumors of various etiology within 8 to 10 months of their life span. The majority of these tumors were found in the pancreas, pituitary, brain, mammary tissue, and skin. In addition, Cdk4R24C/R24C mice showed extraordinary susceptibility to carcinogens and developed papillomas within the first 8 to 10 weeks following cutaneous application of the carcinogens 9,10-di-methyl-1,2-benz[a]anthracene (DMBA) and 12-O-tetradecanoylphorbol-13-acetate (TPA). This report formally establishes that the activation of Cdk4 is sufficient to promote cancer in many tissues. The observation that a wide variety of tumors develop in mice harboring the Cdk4R24C mutation offers a genetic proof that Cdk4 activation may constitute a central event in the genesis of many types of cancers in addition to melanoma.
* Corresponding author. Present address for Sushil G. Rane: Laboratory of Cell Regulation & Carcinogenesis, NCI, NIH, Bldg. 41, 41 Library Dr., Bethesda, MD 20892. Phone: (301) 594-2907. Fax: (301) 496-8395. Mailing address for E. Premkumar Reddy: Fels Institute for Cancer Research and Molecular Biology, Temple University School of Medicine, 3307 North Broad St., Philadelphia, PA 19140. Phone: (215) 707-4307. Fax: (215) 707-1454. E-mail:
reddy{at}unix.temple.edu.
Molecular and Cellular Biology, January 2002, p. 644-656, Vol. 22, No. 2
0022-538X/01/$04.00+0 DOI: 10.1128/MCB.22.2.644-656.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Quereda, V., Malumbres, M.
(2009). Cell cycle control of pituitary development and disease. J Mol Endocrinol
42: 75-86
[Abstract]
[Full Text]
-
Jones, R., Ruas, M., Gregory, F., Moulin, S., Delia, D., Manoukian, S., Rowe, J., Brookes, S., Peters, G.
(2007). A CDKN2A Mutation in Familial Melanoma that Abrogates Binding of p16INK4a to CDK4 but not CDK6. Cancer Res.
67: 9134-9141
[Abstract]
[Full Text]
-
Ruas, M., Gregory, F., Jones, R., Poolman, R., Starborg, M., Rowe, J., Brookes, S., Peters, G.
(2007). CDK4 and CDK6 Delay Senescence by Kinase-Dependent and p16INK4a-Independent Mechanisms. Mol. Cell. Biol.
27: 4273-4282
[Abstract]
[Full Text]
-
Ramsey, M. R., Krishnamurthy, J., Pei, X.-H., Torrice, C., Lin, W., Carrasco, D. R., Ligon, K. L., Xiong, Y., Sharpless, N. E.
(2007). Expression of p16Ink4a Compensates for p18Ink4c Loss in Cyclin-Dependent Kinase 4/6-Dependent Tumors and Tissues. Cancer Res.
67: 4732-4741
[Abstract]
[Full Text]
-
Carbone, C. J., Grana, X., Reddy, E. P., Haines, D. S.
(2007). p21 Loss Cooperates with INK4 Inactivation Facilitating Immortalization and Bcl-2-Mediated Anchorage-Independent Growth of Oncogene-Transduced Primary Mouse Fibroblasts. Cancer Res.
67: 4130-4137
[Abstract]
[Full Text]
-
Jiao, W., Datta, J., Lin, H.-M., Dundr, M., Rane, S. G.
(2006). Nucleocytoplasmic Shuttling of the Retinoblastoma Tumor Suppressor Protein via Cdk Phosphorylation-dependent Nuclear Export. J. Biol. Chem.
281: 38098-38108
[Abstract]
[Full Text]
-
Brocke, J. v., Schmeiser, H. H., Reinbold, M., Hollstein, M.
(2006). MEF immortalization to investigate the ins and outs of mutagenesis. Carcinogenesis
27: 2141-2147
[Abstract]
[Full Text]
-
Tormo, D., Ferrer, A., Gaffal, E., Wenzel, J., Basner-Tschakarjan, E., Steitz, J., Heukamp, L. C., Gutgemann, I., Buettner, R., Malumbres, M., Barbacid, M., Merlino, G., Tuting, T.
(2006). Rapid Growth of Invasive Metastatic Melanoma in Carcinogen-Treated Hepatocyte Growth Factor/Scatter Factor-Transgenic Mice Carrying an Oncogenic CDK4 Mutation. Am. J. Pathol.
169: 665-672
[Abstract]
[Full Text]
-
Braig, M., Schmitt, C. A.
(2006). Oncogene-induced senescence: putting the brakes on tumor development.. Cancer Res.
66: 2881-2884
[Abstract]
[Full Text]
-
Reddy, H. K.D.L., Mettus, R. V., Rane, S. G., Grana, X., Litvin, J., Reddy, E. P.
(2005). Cyclin-Dependent Kinase 4 Expression Is Essential for Neu-Induced Breast Tumorigenesis. Cancer Res.
65: 10174-10178
[Abstract]
[Full Text]
-
Collins, N. L., Reginato, M. J., Paulus, J. K., Sgroi, D. C., LaBaer, J., Brugge, J. S.
(2005). G1/S Cell Cycle Arrest Provides Anoikis Resistance through Erk-Mediated Bim Suppression. Mol. Cell. Biol.
25: 5282-5291
[Abstract]
[Full Text]
-
Jiao, W., Lin, H.-M., Timmons, J., Nagaich, A. K., Ng, S.-W., Misteli, T., Rane, S. G.
(2005). E2F-Dependent Repression of Topoisomerase II Regulates Heterochromatin Formation and Apoptosis in Cells with Melanoma-Prone Mutation. Cancer Res.
65: 4067-4077
[Abstract]
[Full Text]
-
Vries, R. G.J., Bezrookove, V., Zuijderduijn, L. M.P., Kia, S. K., Houweling, A., Oruetxebarria, I., Raap, A. K., Verrijzer, C. P.
(2005). Cancer-associated mutations in chromatin remodeler hSNF5 promote chromosomal instability by compromising the mitotic checkpoint. Genes Dev.
19: 665-670
[Abstract]
[Full Text]
-
Chan, H. M., Narita, M., Lowe, S. W., Livingston, D. M.
(2005). The p400 E1A-associated protein is a novel component of the p53 -> p21 senescence pathway. Genes Dev.
19: 196-201
[Abstract]
[Full Text]
-
Chytil, A., Waltner-Law, M., West, R., Friedman, D., Aakre, M., Barker, D., Law, B.
(2004). Construction of a Cyclin D1-Cdk2 Fusion Protein to Model the Biological Functions of Cyclin D1-Cdk2 Complexes. J. Biol. Chem.
279: 47688-47698
[Abstract]
[Full Text]
-
Miliani de Marval, P. L., Macias, E., Rounbehler, R., Sicinski, P., Kiyokawa, H., Johnson, D. G., Conti, C. J., Rodriguez-Puebla, M. L.
(2004). Lack of Cyclin-Dependent Kinase 4 Inhibits c-myc Tumorigenic Activities in Epithelial Tissues. Mol. Cell. Biol.
24: 7538-7547
[Abstract]
[Full Text]
-
Wolfraim, L. A., Walz, T. M., James, Z., Fernandez, T., Letterio, J. J.
(2004). p21Cip1 and p27Kip1 Act in Synergy to Alter the Sensitivity of Naive T Cells to TGF-{beta}-Mediated G1 Arrest through Modulation of IL-2 Responsiveness. J. Immunol.
173: 3093-3102
[Abstract]
[Full Text]
-
Wallace, M., Ball, K. L.
(2004). Docking-Dependent Regulation of the Rb Tumor Suppressor Protein by Cdk4. Mol. Cell. Biol.
24: 5606-5619
[Abstract]
[Full Text]
-
Oruetxebarria, I., Venturini, F., Kekarainen, T., Houweling, A., Zuijderduijn, L. M. P., Mohd-Sarip, A., Vries, R. G. J., Hoeben, R. C., Verrijzer, C. P.
(2004). p16INK4a Is Required for hSNF5 Chromatin Remodeler-induced Cellular Senescence in Malignant Rhabdoid Tumor Cells. J. Biol. Chem.
279: 3807-3816
[Abstract]
[Full Text]
-
Crabtree, J. S., Scacheri, P. C., Ward, J. M., McNally, S. R., Swain, G. P., Montagna, C., Hager, J. H., Hanahan, D., Edlund, H., Magnuson, M. A., Garrett-Beal, L., Burns, A. L., Ried, T., Chandrasekharappa, S. C., Marx, S. J., Spiegel, A. M., Collins, F. S.
(2003). Of Mice and MEN1: Insulinomas in a Conditional Mouse Knockout. Mol. Cell. Biol.
23: 6075-6085
[Abstract]
[Full Text]
-
Natarajan, E., Saeb, M., Crum, C. P., Woo, S. B., McKee, P. H., Rheinwald, J. G.
(2003). Co-Expression of p16INK4A and Laminin 5 {gamma}2 by Microinvasive and Superficial Squamous Cell Carcinomas in Vivo and by Migrating Wound and Senescent Keratinocytes in Culture. Am. J. Pathol.
163: 477-491
[Abstract]
[Full Text]
-
Wei, W., Jobling, W. A., Chen, W., Hahn, W. C., Sedivy, J. M.
(2003). Abolition of Cyclin-Dependent Kinase Inhibitor p16Ink4a and p21Cip1/Waf1 Functions Permits Ras-Induced Anchorage-Independent Growth in Telomerase-Immortalized Human Fibroblasts. Mol. Cell. Biol.
23: 2859-2870
[Abstract]
[Full Text]
-
Recio, J. A., Noonan, F. P., Takayama, H., Anver, M. R., Duray, P., Rush, W. L., Lindner, G., De Fabo, E. C., DePinho, R. A., Merlino, G.
(2002). Ink4a/Arf Deficiency Promotes Ultraviolet Radiation-induced Melanomagenesis. Cancer Res.
62: 6724-6730
[Abstract]
[Full Text]
-
Zou, X., Ray, D., Aziyu, A., Christov, K., Boiko, A. D., Gudkov, A. V., Kiyokawa, H.
(2002). Cdk4 disruption renders primary mouse cells resistant to oncogenic transformation, leading to Arf/p53-independent senescence. Genes Dev.
16: 2923-2934
[Abstract]
[Full Text]
-
Tanaka, S., Diffley, J. F.X.
(2002). Deregulated G1-cyclin expression induces genomic instability by preventing efficient pre-RC formation. Genes Dev.
16: 2639-2649
[Abstract]
[Full Text]
-
Marcotte, R., Wang, E.
(2002). Replicative Senescence Revisited. Journals of Gerontology Series A: Biological Sciences and Medical Sciences
57: B257-269
[Abstract]
[Full Text]